The Science of Alt Protein: Jumpstarting techno-economic analysis for fermentation
Event speakers
Brentan Alexander, Ph.D.
Crystal Bleecher, P.E.
Webinar description
Fermentation technology holds immense potential in the alternative protein space, but determining commercial-scale production costs has always been a complex and costly challenge for the sector.
In June, Synonym launched Scaler, its new techno-economic analysis tool for fermentation designed to empower alternative protein companies with a better understanding of the unit economics required to launch their bioproducts in the mass market.
Companies looking for a techno-economic analysis for fermentation can now use Scaler to model their costs of building a commercial-scale facility and producing at industrial-scale. Users can refine over 50 parameters in their models, including variables related to fermentation, feedstock, media, downstream processing, financing assumptions and more. After providing these inputs, users receive a customized report with key insights about their process, including a CapEx breakdown, COGS, breakdown, sensitivity analysis, bankability analysis and facility sizing analysis.
During this seminar, the audience will hear directly from the brains behind the model powering Scaler, Brentan Alexander, Chief Investment Officer at Synonym, and Crystal Bleecher, Director of Engineering at Synonym. Combined, Brentan and Crystal have many years of experience financing and designing large-scale infrastructure projects across novel technologies and industries.
Meet the speakers
Brentan Alexander, Ph.D.
CHIEF INVESTMENT OFFICER, SYNONYM
Brentan has a strong entrepreneurial background and has devoted his career to mitigating climate impacts through the commercialization of novel technologies. He has deep technical expertise that allows him to engage with project finance and development at a foundational level, wrapping underlying technical breakthroughs in the required commercial structures to enable financing. He has seen over 1,000 different projects over his career, giving him unparalleled perspective into the structures, risks, and opportunities that are attractive to project finance investors and the minimum requirements to attract capital.
Prior to joining Synonym, Brentan served in numerous executive roles at New Energy Risk, a leading technology performance insurer, and oversaw the underwriting, structuring and execution of every deal that New Energy Risk closed, representing over $2BN in deployed insurance capital and $3BN in total project capital. Prior to New Energy Risk, Brentan was an engineer, tackling projects in failure root-cause analysis, manufacturing quality control, validation test design, engineering design review, and technology R&D for clients including Shell, Microsoft, BP, General Motors, and Columbia Sportswear.
Brentan received his Ph.D. from Stanford University in Mechanical Engineering, where he focused on solid fuel gasification and syngas utilization using solid-oxide fuel cell technology. He is the author of numerous peer-reviewed scientific publications, has presented at a variety of technical symposia, and has been honored as an NDSEG Fellow (2009-2012) and a Rohsenow Fellow (2007-2008). He holds MS and BS degrees in Mechanical Engineering from MIT.
Crystal Bleecher, P.E.
DIRECTOR OF ENGINEERING, SYNONYM
Crystal is a professionally licensed chemical engineer and subject matter expert in fermentation process and facility design. She has over 18 years of experience tackling the challenges of commercializing novel fermentation processes and has extensive experience in process optimization, value engineering, and sterile and hygienic design.
Crystal began her career as a process engineer, working for cellulosic biofuel start-ups. Most recently, she spent 10 years at Merrick & Company, leading a team of process engineers to develop designs for large capital fermentation projects, ranging from $50-$800 million total installed cost. Crystal’s career has been dedicated to developing complex engineering solutions for the renewable fuel & alternative protein industries.
Upcoming events
View all events
Wild Hope: Mission Impossible – Screening & Panel Discussion
The future of food is in focus. Join us for a special screening of Wild Hope: Mission Impossible, an eye-opening film exploring plant-based solutions and the innovations shaping our food…
Fish & CHIPS: Collaborative Huddle for Ideation & Problem Solving
Calling all cultivated seafood researchers and innovators! Join us for our next collaborative huddle on March 25th at 11:30 am ET.
Fish & CHIPS: Collaborative Huddle for Ideation & Problem Solving
Calling all cultivated seafood researchers and innovators! Join us for our next collaborative huddle on March 25th at 10:30 pm ET.
2025 Canadian Alternative Protein Symposium
Join GFI President Bruce Friedrich at the Canadian Alt Protein Symposium, a dynamic gathering of innovators working to reshape the global food system!
The Business of Alt Protein: Precision fermentation consumer research and nomenclature
Join GFI’s next Business of Alt Protein webinar covering an overview of current precision fermentation consumer research insights and nomenclature best practices.
MANRRS 39
Join us for an engaging session on alternative proteins and their potential to transform food systems. This session will explore the science, technology, and market opportunities behind plant-based, cultivated, and…
GFI’s Research Grant Program: 2025 RFP information session
The greatest time of the year is upon us: GFI research grant season! Funding for alternative protein research is up for grabs, and we’ll walk you through GFI’s RFP step-by-step.
The Next Frontier of Food: Precision Fermentation Innovations—ConnectEd Briefs
Join Lucas Eastham, lead scientist, fermentation, for a ConnectEd Brief on precision fermentation. Lucas will discuss how this technology is revolutionizing food production, from alternative proteins to functional ingredients.
